This dual-peptide blend combines two research bioactive sequences: BPC-157, a gastric-derived synthetic peptide fragment, and TB-500 (Thymosin Beta-4 fragment), a stabilized actin-binding regulator analogue
A licensed provider determines whether a compounded medication is appropriate based on an individual patients medical needs
In the rapidly changing world of medical weight loss, new terms and treatments seem to pop up every week
Related Reviews There are no reviews yet
Increased side effects Degraded compounds can cause unexpected reactions, including nausea, dizziness, or digestive issues
It acts as an inhibitor of nicotinamide N-methyltransferase (NNMT), a crucial enzyme involved in energy metabolism and fat storage